Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kai Siebenbrodt

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Der Nervenarzt|March 8, 2020
[Epilepsy in old age]Kai Siebenbrodt, Adam Strzelczyk, Felix Rosenow
Epilepsy & Behavior : E&B|February 6, 2022
Reply to: "Do executive deficits differentiate between autoimmune temporal lobe epilepsy and temporal lobe epilepsies with non-autoimmune etiologies? A critical view on recently published data" by Juri-Alexander Witt and Christoph Helmstaedter (EB-D-21-01129)Nadine Conradi, Marion Behrens, Saskia Elben, et al.
Journal of Clinical Medicine|November 11, 2022
Repetitive Electroencephalography as Biomarker for the Prediction of Survival in Patients with Post-Hypoxic EncephalopathyLaurent M Willems, Felix Rosenow, Susanne Knake, et al.
Epilepsy & Behavior : E&B|October 29, 2021
Executive deficits in neuropsychological testing differentiate between autoimmune temporal lobe epilepsy caused by limbic encephalitis and temporal lobe epilepsies with non-autoimmune etiologiesNadine Conradi, Marion Behrens, Annika Schuster, et al.
Brain Sciences|May 28, 2022
Hippocampal Cytokine Release in Experimental Epileptogenesis-A Longitudinal In Vivo Microdialysis StudyKai Siebenbrodt, Vanessa Schütz, Lara S Costard, et al.
Multiple Sclerosis and Related Disorders|December 13, 2025
Usage and limitations of neuroglial biomarkers NfL and GFAP in urine as non-invasive disease markers in multiple sclerosisKonstantin Kohlhase, Helai Nassir, Christian Grefkes, et al.
Clinical and Translational Medicine|December 12, 2022
Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosisTobias Burkard, Martina Herrero San Juan, Caroline Dreis, et al.
Autoimmunity Reviews|May 22, 2026
Autoimmune encephalitis-associated epilepsy with glutamic acid decarboxylase autoantibodies and type 1 diabetes mellitus: A comprehensive systematic scoping review of a clinical syndromeMohsen Farjoud Kouhanjani, Alina Plautz, Nico Melzer, et al.
Epilepsy & Behavior : E&B|October 7, 2021
Patients' knowledge about epilepsy-related risks, morbidity, and mortality: A multicenter cohort study from GermanyChristina Schwab, Nora-Elena Wadle, Susanne Knake, et al.
Nature Communications|November 24, 2021
G-protein-coupled receptor P2Y10 facilitates chemokine-induced CD4 T cell migration through autocrine/paracrine mediatorsMalarvizhi Gurusamy, Denise Tischner, Jingchen Shao, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Der Nervenarzt|March 8, 2020
[Epilepsy in old age]Kai Siebenbrodt, Adam Strzelczyk, Felix Rosenow
Epilepsy & Behavior : E&B|February 6, 2022
Reply to: "Do executive deficits differentiate between autoimmune temporal lobe epilepsy and temporal lobe epilepsies with non-autoimmune etiologies? A critical view on recently published data" by Juri-Alexander Witt and Christoph Helmstaedter (EB-D-21-01129)Nadine Conradi, Marion Behrens, Saskia Elben, et al.
Journal of Clinical Medicine|November 11, 2022
Repetitive Electroencephalography as Biomarker for the Prediction of Survival in Patients with Post-Hypoxic EncephalopathyLaurent M Willems, Felix Rosenow, Susanne Knake, et al.
Epilepsy & Behavior : E&B|October 29, 2021
Executive deficits in neuropsychological testing differentiate between autoimmune temporal lobe epilepsy caused by limbic encephalitis and temporal lobe epilepsies with non-autoimmune etiologiesNadine Conradi, Marion Behrens, Annika Schuster, et al.
Brain Sciences|May 28, 2022
Hippocampal Cytokine Release in Experimental Epileptogenesis-A Longitudinal In Vivo Microdialysis StudyKai Siebenbrodt, Vanessa Schütz, Lara S Costard, et al.
Multiple Sclerosis and Related Disorders|December 13, 2025
Usage and limitations of neuroglial biomarkers NfL and GFAP in urine as non-invasive disease markers in multiple sclerosisKonstantin Kohlhase, Helai Nassir, Christian Grefkes, et al.
Clinical and Translational Medicine|December 12, 2022
Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosisTobias Burkard, Martina Herrero San Juan, Caroline Dreis, et al.
Autoimmunity Reviews|May 22, 2026
Autoimmune encephalitis-associated epilepsy with glutamic acid decarboxylase autoantibodies and type 1 diabetes mellitus: A comprehensive systematic scoping review of a clinical syndromeMohsen Farjoud Kouhanjani, Alina Plautz, Nico Melzer, et al.
Epilepsy & Behavior : E&B|October 7, 2021
Patients' knowledge about epilepsy-related risks, morbidity, and mortality: A multicenter cohort study from GermanyChristina Schwab, Nora-Elena Wadle, Susanne Knake, et al.
Nature Communications|November 24, 2021
G-protein-coupled receptor P2Y10 facilitates chemokine-induced CD4 T cell migration through autocrine/paracrine mediatorsMalarvizhi Gurusamy, Denise Tischner, Jingchen Shao, et al.
Pageof 3